Basic Information
ID: ALA3537726
Type: ADME
Description: Drug level in human plasma assessed as compound formation treated with [14C]brivanib alaninate at 800 mg, po administered as single dose via gavage measured after 4 hrs by mass spectrometry
Organism: Homo sapiens
Tissue: Plasma
Activity Charts
Bioactivity
Activity Types for Assay ALA3537726
Compound recovery
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 368.37 | 3.73 | 3.73 |